Treatment Options for HIV‐Associated Tuberculosis | Zendy

Philip Onyebujoh | Zendy; Isabela Ribeiro | Zendy; Christopher C. Whalen | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Treatment Options for HIV‐Associated Tuberculosis

Author(s) -

Philip Onyebujoh,

Isabela Ribeiro,

Christopher C. Whalen

Publication year - 2007

Publication title -

the journal of infectious diseases

Language(s) - Uncategorized

Resource type - Journals

SCImago Journal Rank - 2.69

H-Index - 252

eISSN - 1537-6613

pISSN - 0022-1899

DOI - 10.1086/518657

Subject(s) - tuberculosis , medicine , human immunodeficiency virus (hiv) , context (archaeology) , intensive care medicine , pandemic , antiretroviral therapy , immunology , covid-19 , viral load , disease , pathology , infectious disease (medical specialty) , biology , paleontology

The vicious interaction between the human immunodeficiency virus (HIV) infection and tuberculosis (TB) pandemics poses special challenges to national control programs and individual physicians. Although recommendations for the treatment of TB in HIV-infected patients do not significantly differ from those for HIV-uninfected patients, the appropriate management of HIV-associated TB is complicated by health system issues, diagnostic difficulties, adherence concerns, overlapping adverse-effect profiles and drug interactions, and the occurrence of paradoxical reactions after the initiation of effective antiretroviral therapy. In this article, recommended treatment strategies and novel approaches to the management of HIV-associated TB are reviewed, including adjuvant treatment and options for treatment simplification. A focused research agenda is proposed in the context of the limitations of the current knowledge framework.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research